PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1997 June; 90(6): 307–311.
PMCID: PMC1296305

Angiogenesis and the heart: therapeutic implications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (890K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gimbrone MA, Jr, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst. 1974 Feb;52(2):413–427. [PubMed]
  • Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science. 1984 Mar 23;223(4642):1296–1299. [PubMed]
  • Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. [PubMed]
  • Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971 Feb 1;133(2):275–288. [PMC free article] [PubMed]
  • Schaper W, Vandesteene R. The rate of growth of interarterial anastomoses in chronic coronary artery occlusion. Life Sci. 1967 Aug 1;6(15):1673–1680. [PubMed]
  • Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res. 1996 Nov;79(5):911–919. [PubMed]
  • Gupta BN, Abboud AL, Floras JS, Aylward PE, Abboud FM. Vasopressin facilitates inhibition of renal nerve activity mediated through vagal afferents. Am J Physiol. 1987 Jul;253(1 Pt 2):H1–H7. [PubMed]
  • Roth DM, White FC, Bloor CM. Altered minimal coronary resistance to antegrade reflow after chronic coronary artery occlusion in swine. Circ Res. 1988 Aug;63(2):330–339. [PubMed]
  • Roth DM, White FC, Nichols ML, Dobbs SL, Longhurst JC, Bloor CM. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation. 1990 Nov;82(5):1778–1789. [PubMed]
  • Takahashi M, Yui Y, Yasumoto H, Aoyama T, Morishita H, Hattori R, Kawai C. Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol. 1990 Jan;258(1 Pt 2):H1–H8. [PubMed]
  • Moore JW, 3rd, Sholley MM. Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas. Am J Pathol. 1985 Jul;120(1):87–98. [PubMed]
  • Sunderkötter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther. 1991;51(2):195–216. [PubMed]
  • Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 1996 Aug 15;94(4):610–613. [PubMed]
  • Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol. 1991;53:217–239. [PubMed]
  • Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989 Apr 13;338(6216):557–562. [PubMed]
  • Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li J, Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol. 1996 Aug;271(2 Pt 2):H713–H720. [PubMed]
  • Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest. 1994 Nov;94(5):2036–2044. [PMC free article] [PubMed]
  • Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996 Jan;270(1 Pt 2):H411–H415. [PubMed]
  • Hawker JR, Jr, Granger HJ. Tyrosine kinase inhibitors impair fibroblast growth factor signaling in coronary endothelial cells. Am J Physiol. 1994 Jan;266(1 Pt 2):H107–H120. [PubMed]
  • Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, Maragoudakis ME. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol. 1995 Sep;116(2):1829–1834. [PMC free article] [PubMed]
  • Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992 Sep 4;257(5075):1401–1403. [PubMed]
  • Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994 Aug;94(2):623–630. [PMC free article] [PubMed]
  • Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG, Jr, Stiber JA, Correa R, Epstein SE, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995 Jan 1;91(1):145–153. [PubMed]
  • Unger EF, Banai S, Shou M, Jaklitsch M, Hodge E, Correa R, Jaye M, Epstein SE. A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs. Cardiovasc Res. 1993 May;27(5):785–791. [PubMed]
  • Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 1996 Jun;63(1):77–82. [PubMed]
  • Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994 May;89(5):2183–2189. [PubMed]
  • Harada K, Friedman M, Lopez JJ, Wang SY, Li J, Prasad PV, Pearlman JD, Edelman ER, Sellke FW, Simons M. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 1996 May;270(5 Pt 2):H1791–H1802. [PubMed]
  • Giordano FJ, Ping P, McKirnan MD, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O, Hammond HK. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med. 1996 May;2(5):534–539. [PubMed]
  • Harrison DG, Chilian WM, Marcus ML. Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res. 1986 Aug;59(2):133–142. [PubMed]
  • Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, Simons M. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol. 1994 Oct;267(4 Pt 2):H1303–H1311. [PubMed]
  • Sellke FW, Wang SY, Friedman M, Dai HB, Harada K, Lopez JJ, Simons M. Beta-adrenergic modulation of the collateral-dependent coronary microcirculation. J Surg Res. 1995 Jul;59(1):185–190. [PubMed]
  • Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996 Aug 10;348(9024):370–374. [PubMed]
  • Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med. 1997 Feb;3(2):158–164. [PubMed]
  • Smith SC., Jr AHA president's letter. Circulation. 1995 Jul 1;92(1):1–1. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press